APA

Salcedo M., Lendvai N., Mastey D., Schlossman J., Hultcrantz M., Korde N., Mailankody S., Lesokhin A., Hassoun H., Smith E., Shah U., Diab V., Werner K., Landau H., Lahoud O., Drullinsky P., Shah G., Chung D., Scordo M., Giralt S. & Landgren O. (20210514). Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. : Clinical lymphoma, myeloma & leukemia.

Chicago

Salcedo Meghan, Lendvai Nikoletta, Mastey Donna, Schlossman Julia, Hultcrantz Malin, Korde Neha, Mailankody Sham, Lesokhin Alexander, Hassoun Hani, Smith Eric, Shah Urvi, Diab Victoria, Werner Kelly, Landau Heather, Lahoud Oscar, Drullinsky Pamela, Shah Gunjan, Chung David, Scordo Michael, Giralt Sergio and Landgren Ola. 20210514. Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. : Clinical lymphoma, myeloma & leukemia.

Harvard

Salcedo M., Lendvai N., Mastey D., Schlossman J., Hultcrantz M., Korde N., Mailankody S., Lesokhin A., Hassoun H., Smith E., Shah U., Diab V., Werner K., Landau H., Lahoud O., Drullinsky P., Shah G., Chung D., Scordo M., Giralt S. and Landgren O. (20210514). Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. : Clinical lymphoma, myeloma & leukemia.

MLA

Salcedo Meghan, Lendvai Nikoletta, Mastey Donna, Schlossman Julia, Hultcrantz Malin, Korde Neha, Mailankody Sham, Lesokhin Alexander, Hassoun Hani, Smith Eric, Shah Urvi, Diab Victoria, Werner Kelly, Landau Heather, Lahoud Oscar, Drullinsky Pamela, Shah Gunjan, Chung David, Scordo Michael, Giralt Sergio and Landgren Ola. Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. : Clinical lymphoma, myeloma & leukemia. 20210514.